Jörg C. Prinz

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

Kim Papp, Stephen K. Tyring, M. Lahfa et al. · British Journal of Dermatology · 2005 · 692 citations

Medicine, Dermatology, Pharmacotherapy +8

Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

Kamran Ghoreschi, Peter Thomas, Susanne Breit et al. · Nature Medicine · 2002 · 454 citations

Life Sciences, Dermatology, Immunology +16

Melanocyte antigen triggers autoimmunity in human psoriasis

Akiko Arakawa, Katherina Siewert, Julia Stöhr et al. · The Journal of Experimental Medicine · 2015 · 354 citations · Full text

Life Sciences, Dermatology, Immunology +17

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

Andrew Blauvelt, Jörg C. Prinz, Alice B. Gottlieb et al. · British Journal of Dermatology · 2014 · 320 citations

Medicine, Dermatology, Pharmacology +17

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis

Kenneth B. Gordon, Kristina Callis Duffin, Robert Bissonnette et al. · New England Journal of Medicine · 2015 · 298 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15